# Alistair Burns

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/alistair-burns/

## Facts

| Field | Value |
| --- | --- |
| Citations | 56,726 |
| Field | Dementia and Cognitive Impairment Research |
| h-index | 97 |
| i10-index | 352 |
| Last Known Institution | The University of Melbourne |
| OpenAlex ID | https://openalex.org/A5027171288 |
| ORCID iD | https://orcid.org/0000-0002-9837-0645 |
| Works | 767 |

## Researcher papers

- [Dementia prevention, intervention, and care: 2020 report of the Lancet Commission](https://scholariq.org/papers/dementia-prevention-intervention-and-care-2020-report-of-the-lancet-commission/)
- [Dementia prevention, intervention, and care](https://scholariq.org/papers/dementia-prevention-intervention-and-care/)
- [Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB)](https://scholariq.org/papers/consensus-guidelines-for-the-clinical-and-pathologic-diagnosis-of-dementia-with/)
- [Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission](https://scholariq.org/papers/dementia-prevention-intervention-and-care-2024-report-of-the-lancet-standing/)
- [Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease](https://scholariq.org/papers/donepezil-and-memantine-for-moderate-to-severe-alzheimer-s-disease/)
- [Core outcome measures for interventions to prevent or slow the progress of dementia for people living with mild to moderate dementia: Systematic review and consensus recommendations](https://scholariq.org/papers/core-outcome-measures-for-interventions-to-prevent-or-slow-the-progress-of/)
- [Efficacy and Tolerability of Donepezil in Vascular Dementia](https://scholariq.org/papers/efficacy-and-tolerability-of-donepezil-in-vascular-dementia/)
- [Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology](https://scholariq.org/papers/clinical-practice-with-anti-dementia-drugs-a-revised-third-consensus-statement/)
- [Drug repositioning for Alzheimer's disease](https://scholariq.org/papers/drug-repositioning-for-alzheimer-s-disease/)
- [The impact of individual Cognitive Stimulation Therapy (iCST) on cognition, quality of life, caregiver health, and family relationships in dementia: A randomised controlled trial](https://scholariq.org/papers/the-impact-of-individual-cognitive-stimulation-therapy-icst-on-cognition-quality/)

## Researcher topics

- [Dementia and Cognitive Impairment Research](https://scholariq.org/topics/dementia-and-cognitive-impairment-research/)
- [Alzheimer's disease research and treatments](https://scholariq.org/topics/alzheimer-s-disease-research-and-treatments/)
- [Geriatric Care and Nursing Homes](https://scholariq.org/topics/geriatric-care-and-nursing-homes/)
- [Schizophrenia research and treatment](https://scholariq.org/topics/schizophrenia-research-and-treatment/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)

## Researcher university

- [The University of Melbourne](https://scholariq.org/institutions/the-university-of-melbourne/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.